Hanmi Science (008930) financial statements
+515.7%since 2013
- FY2025 revenue
- ₩1.4T▲ +5.7%
- FY2025 net income
- ₩118.4B▲ +99.2%
- FY2025 diluted EPS
- ₩1,747.00▲ +99.0%
Hanmi Science income statement
| KRW millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 1,356,958 | 1,283,432 | 1,247,906 |
| Operating income | 138,727 | 98,868 | 124,469 |
| Pretax income | 133,003 | 63,095 | 130,542 |
| Net income | 118,370 | 59,422 | 115,122 |
| Diluted earnings per share | 1,747.00 | 878.00 | 1,694.00 |
Hanmi Science balance sheet
| KRW millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 127,389 | 85,228 | 27,579 |
| Total assets | 1,489,047 | 1,349,079 | 1,226,170 |
| Total liabilities | 529,854 | 510,375 | 438,698 |
| Total equity | 959,193 | 838,704 | 787,472 |
| Long-term debt | 0 | 350 | 10,197 |
Hanmi Science cash flow statement
| KRW millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 47,658 | 82,986 | 35,158 |
| Dividends paid | -13,543 | -20,324 | -13,333 |
Quarterly highlights
| KRW millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 362,878 | 367,856 | 353,703 | 344,026 |
| Operating income (derived) | 19,150 | 59,138 | 33,562 | 37,747 |
| Net income (derived) | 15,574 | 43,666 | 42,708 | 32,259 |
| Diluted earnings per share | 230.00 | 644.00 | 630.00 | n/a |
| Operating cash flow (derived) | 8,791 | 10,441 | 7,959 | 10,116 |
| Total assets | 1,534,915 | 1,532,593 | 1,494,914 | 1,489,047 |
Hanmi Science major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| 송영숙 | 71.2% | 48,659,690 | 12 November 2026 |
| DXVX | 7.6% | 5,186,536 | 10 August 2026 |
| 임종훈 | 7.6% | 5,186,536 | 10 August 2026 |
Hanmi Science DART filings
| Filed | Form | Type |
|---|---|---|
| 12 November 2026 | Quarterly Report | Quarterly report |
| 13 August 2026 | Semiannual Report | Half-year report |
| 27 July 2026 | Major Matters Report | Current report |
| 14 May 2026 | Quarterly Report | Quarterly report |
| 19 March 2026 | Business Report | Annual report |
| 8 January 2026 | Major Matters Report | Current report |
| 13 November 2025 | Quarterly Report | Quarterly report |
Common questions
What was Hanmi Science's revenue in fiscal 2025?
Hanmi Science reported ₩1.4 trillion in revenue for fiscal 2025, the year ended 31 December 2025, up 5.7% from fiscal 2024.
What was Hanmi Science's net income in fiscal 2025?
Hanmi Science reported net income of ₩118.4 billion for fiscal 2025, the year ended 31 December 2025, up 99.2% from fiscal 2024. Diluted earnings per share were ₩1,747.00.
What were Hanmi Science's total assets at the end of fiscal 2025?
Hanmi Science reported total assets of ₩1.5 trillion at the end of fiscal 2025, the year ended 31 December 2025.
Who reported holding 5% or more of Hanmi Science?
송영숙 reported holding 71.2% of a class of Hanmi Science shares in a filing dated 12 November 2026.
How much Hanmi Science history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.